These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34854171)

  • 1. Cardiometabolic health risks, lifestyle behaviours and quality of life in people diagnosed with early psychosis - A cross-sectional study.
    Meepring S; Gray R; Li Y; Ho G; Chien WT; Bressington D
    J Psychiatr Ment Health Nurs; 2022 Aug; 29(4):578-591. PubMed ID: 34854171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study.
    Bressington D; Mui J; Tse ML; Gray R; Cheung EF; Chien WT
    BMC Psychiatry; 2016 Nov; 16(1):411. PubMed ID: 27863522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease lifestyle risk factors in people with psychosis: a cross-sectional study.
    Mucheru D; Hanlon MC; Campbell LE; McEvoy M; MacDonald-Wicks L
    BMC Public Health; 2018 Jun; 18(1):742. PubMed ID: 29907101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The physical health of people with schizophrenia in Asia: Baseline findings from a physical health check programme.
    Thongsai S; Gray R; Bressington D
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):255-66. PubMed ID: 27090192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic Risk in First Episode Psychosis Patients.
    Smith J; Griffiths LA; Band M; Horne D
    Front Endocrinol (Lausanne); 2020; 11():564240. PubMed ID: 33329382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCT.
    Holt RI; Hind D; Gossage-Worrall R; Bradburn MJ; Saxon D; McCrone P; Morris TA; Etherington A; Shiers D; Barnard K; Swaby L; Edwardson C; Carey ME; Davies MJ; Dickens CM; Doherty Y; French P; Greenwood KE; Kalidindi S; Khunti K; Laugharne R; Pendlebury J; Rathod S; Siddiqi N; Wright S; Waller G; Gaughran F; Barnett J; Northern A
    Health Technol Assess; 2018 Nov; 22(65):1-160. PubMed ID: 30499443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a cost-effective CVD prediction model using lifestyle factors. A cohort study in Pakistan.
    Naheeda P; Sharifullah K; Ullah SS; Azeem AM; Shahzad Y; Kinza W
    Afr Health Sci; 2020 Jun; 20(2):849-859. PubMed ID: 33163052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of the Lifestyle Interventions for severe mentally ill Outpatients in the Netherlands (LION) trial; a cluster randomised controlled study of a multidimensional web tool intervention to improve cardiometabolic health in patients with severe mental illness.
    Looijmans A; Jörg F; Bruggeman R; Schoevers R; Corpeleijn E
    BMC Psychiatry; 2017 Mar; 17(1):107. PubMed ID: 28327086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nurse-led GILL eHealth intervention for improving physical health and lifestyle behaviours in clients with severe mental illness: design of a cluster-randomised controlled trial.
    Hoogervorst MM; van Meijel B; Bruin EK; Beekman A; Boonstra N; Adriaanse M
    BMC Psychiatry; 2023 Sep; 23(1):672. PubMed ID: 37715156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trial.
    Krause N; Derad C; von Glasenapp B; Riemann-Lorenz K; Temmes H; van de Loo M; Friede T; Asendorf T; Heesen C;
    Mult Scler Relat Disord; 2023 Nov; 79():105043. PubMed ID: 37839367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year cardiovascular disease risk and related factors in lifetime marijuana use with comorbid methamphetamine-associated psychotic disorder: a QRISK
    Örüm D; Örüm MH; Kapıcı Y; Abuş S
    BMC Psychiatry; 2024 Aug; 24(1):563. PubMed ID: 39160490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study.
    Gaughran F; Stahl D; Stringer D; Hopkins D; Atakan Z; Greenwood K; Patel A; Smith S; Gardner-Sood P; Lally J; Heslin M; Stubbs B; Bonaccorso S; Kolliakou A; Howes O; Taylor D; Forti MD; David AS; Murray RM; Ismail K;
    Br J Psychiatry; 2019 Dec; 215(6):712-719. PubMed ID: 31347480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary patterns and physical activity in people with schizophrenia and increased waist circumference.
    Jakobsen AS; Speyer H; Nørgaard HCB; Karlsen M; Hjorthøj C; Krogh J; Mors O; Nordentoft M; Toft U
    Schizophr Res; 2018 Sep; 199():109-115. PubMed ID: 29555213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life, symptom severity and level of functioning in people with severe mental illness ready for hospital discharge.
    Tong Chien W; Thompson DR; Fong Leung S; Bressington D
    J Psychiatr Ment Health Nurs; 2022 Feb; 29(1):14-24. PubMed ID: 33067830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, cardiovascular risk, and lifestyle: cross-sectional and prospective analyses in a nationwide Spanish cohort.
    Valenzuela PL; Santos-Lozano A; Saco-Ledo G; Castillo-García A; Lucia A
    Eur J Prev Cardiol; 2023 Oct; 30(14):1493-1501. PubMed ID: 37317985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of lifestyle intervention strategies targeting weight outcomes in people with psychosis: a systematic review and network meta-analysis.
    Mucheru D; Hanlon MC; McEvoy M; Thakkinstian A; MacDonald-Wicks L
    JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1770-1825. PubMed ID: 31343494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial.
    Storch Jakobsen A; Speyer H; Nørgaard HCB; Hjorthøj C; Krogh J; Mors O; Nordentoft M
    Schizophr Res; 2018 Sep; 199():96-102. PubMed ID: 29501386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiometabolic risk factors, physical activity and psychiatric status in patients in long-term psychiatric inpatient departments.
    Ringen PA; Faerden A; Antonsen B; Falk RS; Mamen A; Rognli EB; Solberg DK; Andreassen OA; Martinsen EW
    Nord J Psychiatry; 2018 May; 72(4):296-302. PubMed ID: 29523041
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.